General PopulationNCT05530720
Acceptance of Complementary Medicine in Germany
An observational study of General Population, run by Charite University, Berlin, Germany at 2 sites in Germany.
Trial summary
Complementary medicine is widely practiced in Germany and worldwide. The aim of this study is to explore how many people use complementary medicine methods in Germany, for which health-related issues they do and for which they would not. Read more about this study
- Who is it for?
- Ages 18 to 110 yearsHealthy volunteers can take part
- Conditions the study is for
- General Population
- What is being tested?
- Cross-sectional survey
- How many people
- 4,505 participants
- Where
- 2 sitesGermany
- Study dates
- 19 Sep 2022to 17 Oct 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 110 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Respondents are recruited from Respondi institute's pool of test persons, but remain completely anonymous with regard to their personal data and answers; they are also not subsequently or indirectly identifiable.
Who may be able to join
- Informed consent
- Age at least 18 years
- Sufficient language skills as well as cognitive ability to participate in an online survey or interview lasting approximately 30 minutes
- Active consent to the online consent form
Who cannot join
- Lack of consent to participate in the study
Trial locations and contacts
2 sites in 1 country.
Germany2 sites
Otto-Friedrich-University Bamberg
Bamberg, 96047
Charité Hochschulambulanz für Naturheilkunde, Immanuel Krankenhaus Berlin
Berlin, 14163
About this study
Official title: Acceptance of Complementary Medicine in Germany - an Anonymous Representative Cross-sectional Study Including a Qualitative Survey
Complementary medicine is widely practiced in Germany and worldwide. The aim of this study is to explore how many people use complementary medicine methods in Germany, for which health-related issues they do and for which they would not.
- Conditions
- General Population
- Being tested
- Cross-sectional survey
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cross-sectional surveyOther
No intervention.
| Study group | Role | What they receive |
|---|---|---|
| Online survey with 3.000 participants using mobile website technology | Not described Receives: Other: Cross-sectional survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of attitudes towards complementary medicine
Assessed retrospectively with self-designed questions
Measured: Up to 24 weeks
Secondary outcomes (6)
Sociodemographic Parameters
Assessed retrospectively with self-designed questions
Measured: Up to 24 weeks
Assessment of knowledge of complementary medicine
Assessed retrospectively with self-designed questions
Measured: Up to 24 weeks
Assessment of own application of complementary medicine
Assessed retrospectively with self-designed questions
Measured: Up to 24 weeks
Assessment of medical history and quality of life by EQ-5D-5L
Assessed retrospectively with self-designed questions
Measured: Up to 24 weeks
Assessment of attitudinal and behavioral questions (e.g. lifestyle)
Assessed retrospectively with self-designed questions
Measured: Up to 24 weeks
Assessment of use of complementary medicine in the Covid-19 pandemic
Assessed retrospectively with self-designed questions
Measured: Up to 24 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Sep 2022
- Study start19 Sep 2022
- Primary completion17 Oct 2022
- Study completion17 Oct 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for General PopulationStudies of the same condition, open and under way.
- More trials run by Charite University, Berlin, GermanyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 4,505 participants (actual)
Sponsor and investigators
- Lead sponsor
- Charite University, Berlin, Germany
- Sponsor type
- University, hospital or other
- Collaborators
- Otto-Friedrich-University Bamberg, Chair of Sociology, Prof. Dr. Rasmus Hoffmann
- Responsible party
- Principal investigator, Dr. Christian S. Kessler, Charite University, Berlin, Germany
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05530720
- Sponsor's protocol ID
- Complementary Medicine Survey
- Status last verified
- Feb 2024
- First submitted
- 26 Aug 2022
- Last updated
- 7 Feb 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Ortiz M, Wischnewsky M, Jeitler M, Brinkhaus B, Michalsen A, Hoffmann R, Kessler CS. Health-Related quality of life and the impact of traditional, complementary and integrative Medicine - an Online - Representative Cross-Sectional survey in Germany. BMC Public Health. 2025 Aug 21;25(1):2870. doi: 10.1186/s12889-025-23908-5.
PubMed 40841634Lehmann J, Trubner M, Patzina A, Jeitler M, Hoffmann R, Kessler CS. The willingness to transition to a more plant-based diet among omnivores: Determinants and socioeconomic differences. Appetite. 2025 Feb 1;206:107765. doi: 10.1016/j.appet.2024.107765. Epub 2024 Nov 12.
PubMed 39536905
Study at a glance
From the registry record, last updated by the sponsor on 7 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Acceptance of Complementary Medicine in Germany - an Anonymous Representative Cross-sectional Study Including a Qualitative Survey
- ClinicalTrials.gov ID
- NCT05530720
- Acronym / sponsor ID
- Complementary Medicine Survey
- Conditions
- General Population
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 4,505 participants (actual)
- Lead sponsor
- Charite University, Berlin, GermanyUniversity, hospital or other
- Collaborators
- Otto-Friedrich-University Bamberg, Chair of Sociology, Prof. Dr. Rasmus Hoffmann
- Study start
- 19 Sep 2022 (actual)
- Primary completion
- 17 Oct 2022 (actual)
- Study completion
- 17 Oct 2022 (actual)
- First posted
- 7 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Complementary medicine is widely practiced in Germany and worldwide. The aim of this study is to explore how many people use complementary medicine methods in Germany, for which health-related issues they do and for which they would not.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Online survey with 3.000 participants using mobile website technology | – | Other: Cross-sectional survey |
Who may qualify
- Ages
- 18 to 110 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Respondents are recruited from Respondi institute's pool of test persons, but remain completely anonymous with regard to their personal data and answers; they are also not subsequently or indirectly identifiable.
Key inclusion criteria (4 listed)
- Informed consent
- Age at least 18 years
- Sufficient language skills as well as cognitive ability to participate in an online survey or interview lasting approximately 30 minutes
- Active consent to the online consent form
Key exclusion criteria (1 listed)
- Lack of consent to participate in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cross-sectional surveyNo intervention. | Other | Online survey with 3.000 participants using mobile website technology |
Primary outcome
Assessment of attitudes towards complementary medicine
Time frame: Up to 24 weeks
Assessed retrospectively with self-designed questions
6 secondary outcomes
Sociodemographic Parameters
Time frame: Up to 24 weeks
Assessment of knowledge of complementary medicine
Time frame: Up to 24 weeks
Assessment of own application of complementary medicine
Time frame: Up to 24 weeks
Assessment of medical history and quality of life by EQ-5D-5L
Time frame: Up to 24 weeks
Assessment of attitudinal and behavioral questions (e.g. lifestyle)
Time frame: Up to 24 weeks
Assessment of use of complementary medicine in the Covid-19 pandemic
Time frame: Up to 24 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Feb 2024.
- Derived from this study: PubMed 40841634Ortiz M, Wischnewsky M, Jeitler M, Brinkhaus B, Michalsen A, Hoffmann R, Kessler CS. Health-Related quality of life and the impact of traditional, complementary and integrative Medicine - an Online - Representative Cross-Sectional survey in Germany. BMC Public Health. 2025 Aug 21;25(1):2870. doi: 10.1186/s12889-025-23908-5.
- Derived from this study: PubMed 39536905Lehmann J, Trubner M, Patzina A, Jeitler M, Hoffmann R, Kessler CS. The willingness to transition to a more plant-based diet among omnivores: Determinants and socioeconomic differences. Appetite. 2025 Feb 1;206:107765. doi: 10.1016/j.appet.2024.107765. Epub 2024 Nov 12.
Related trials for General Population
RecruitingPhase 3
A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment
Generalized Anxiety Disorder
Not yet recruiting
ADVA ACE Coronary Stent System in Coronary Artery Disease Patients (ADVANCE)
Coronary Artery Disease, De Novo Stenosis Lesion
Active, not recruiting
Targeting Social Function in Anxiety and Eating Disorders
Eating Disorders, Anorexia Nervosa
Active, not recruiting
PREWELL Digital Well-being Promotion Intervention With the BitHabit App
General Mental Health and Well-Being, Mental Disorders
Not yet recruiting
CannaRiver CBD Calm for Anxiety, Sleep, and Well-Being in Adults With Generalized Anxiety Disorder
Generalized Anxiety Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of General Population, run by Charite University, Berlin, Germany at 2 sites in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of attitudes towards complementary medicine (time frame: Up to 24 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05530720, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2024.